Abstract
S18 Ustekinumab and Vedolizumab Drug and Anti-Drug Antibody Monitoring: Analysis of 45,429 Patient Results Using Lab Developed Chemiluminescent Immunoassays
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have